Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9BioMarin Pharmaceutical

02 3Biomarin International Limited

03 3Drac Ag

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

VOSORITIDE

Brand Name : VOXZOGO

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 0.4MG/VIAL

Packaging :

Approval Date : 2021-11-19

Application Number : 214938

Regulatory Info : RX

Registration Country : USA

blank

02

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

VOSORITIDE

Brand Name : VOXZOGO

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 0.56MG/VIAL

Packaging :

Approval Date : 2021-11-19

Application Number : 214938

Regulatory Info : RX

Registration Country : USA

blank

03

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

VOSORITIDE

Brand Name : VOXZOGO

Dosage Form : POWDER;SUBCUTANEOUS

Dosage Strength : 1.2MG/VIAL

Packaging :

Approval Date : 2021-11-19

Application Number : 214938

Regulatory Info : RX

Registration Country : USA

blank

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

vosoritide

Brand Name : Voxzogo

Dosage Form :

Dosage Strength :

Packaging : 10

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

vosoritide

Brand Name : Voxzogo

Dosage Form :

Dosage Strength :

Packaging : 10

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

vosoritide

Brand Name : Voxzogo

Dosage Form :

Dosage Strength :

Packaging : 10

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Vosoritide

Brand Name : Voxzogo

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 1.2MG

Packaging :

Approval Date : 2022-01-20

Application Number : 1211577003

Regulatory Info : Authorized

Registration Country : Spain

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Vosoritide

Brand Name : Voxzogo

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 0.4MG

Packaging :

Approval Date : 2022-01-20

Application Number : 1211577001

Regulatory Info : Authorized

Registration Country : Spain

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

Vosoritide

Brand Name : Voxzogo

Dosage Form : Powder And Solvent For Injectable Solution

Dosage Strength : 0.56MG

Packaging :

Approval Date : 2022-01-20

Application Number : 1211577002

Regulatory Info : Authorized

Registration Country : Spain

blank

10

Biomarin International Limited

Country
The MedTech Conference
Not Confirmed
arrow

Biomarin International Limited

Country
arrow
The MedTech Conference
Not Confirmed

Vosoritid

Brand Name : Voxzogo

Dosage Form : Solution For Injection

Dosage Strength : 0.4mg

Packaging :

Approval Date : 26/08/2021

Application Number : 20200724000018

Regulatory Info : Approved

Registration Country : Sweden

blank

11

Biomarin International Limited

Country
The MedTech Conference
Not Confirmed
arrow

Biomarin International Limited

Country
arrow
The MedTech Conference
Not Confirmed

Vosoritid

Brand Name : Voxzogo

Dosage Form : Solution For Injection

Dosage Strength : 0.56mg

Packaging :

Approval Date : 26/08/2021

Application Number : 20200724000025

Regulatory Info : Approved

Registration Country : Sweden

blank

12

Biomarin International Limited

Country
The MedTech Conference
Not Confirmed
arrow

Biomarin International Limited

Country
arrow
The MedTech Conference
Not Confirmed

Vosoritid

Brand Name : Voxzogo

Dosage Form : Solution For Injection

Dosage Strength : 1.2mg

Packaging :

Approval Date : 26/08/2021

Application Number : 20200724000032

Regulatory Info : Approved

Registration Country : Sweden

blank

13

Drac Ag

Country
The MedTech Conference
Not Confirmed
arrow

Drac Ag

Country
arrow
The MedTech Conference
Not Confirmed

Vosoritidum

Brand Name : Voxzogo

Dosage Form : Solution For Injection

Dosage Strength : 0.4mg/5ml

Packaging :

Approval Date : 30/01/2025

Application Number : 69569

Regulatory Info : Allowed

Registration Country : Switzerland

blank

14

Drac Ag

Country
The MedTech Conference
Not Confirmed
arrow

Drac Ag

Country
arrow
The MedTech Conference
Not Confirmed

Vosoritidum

Brand Name : Voxzogo

Dosage Form : Solution For Injection

Dosage Strength : 0.56mg

Packaging :

Approval Date : 30/01/2025

Application Number : 69569

Regulatory Info : Allowed

Registration Country : Switzerland

blank

15

Drac Ag

Country
The MedTech Conference
Not Confirmed
arrow

Drac Ag

Country
arrow
The MedTech Conference
Not Confirmed

Vosoritidum

Brand Name : Voxzogo

Dosage Form : Solution For Injection

Dosage Strength : 1.2mg/0.6ml

Packaging :

Approval Date : 30/01/2025

Application Number : 69569

Regulatory Info : Allowed

Registration Country : Switzerland

blank